Syneos Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Syneos Health sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials 1 currently recruiting 1 completed upper quartile by trial count

Syneos Health: 4 sponsored US clinical trials, 1 recruiting.

Syneos Health sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Hepatitis B, with 1 trials.

Upper-quartile sponsor footprint

Syneos Health sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

4 total, page 1 of 1

RECRUITING

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

NCT00404989
TERMINATED

The Savella Pregnancy Registry

NCT01026077
COMPLETED

Betaseron Pregnancy Registry

NCT00317564
TERMINATED

The Ribavirin Pregnancy Registry

NCT00114712

Therapeutic Areas

Hepatitis B 1
HIV Infections 1

What is open in the Syneos Health pipeline

1 recruiting of 4 indexed (25% open); 1 completed (25%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hepatitis B (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Syneos Health: open-pipeline peers nationwide

Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Syneos Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%20%40%60%80% Total trials Recruiting share Syneos Health4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action LabAB ScienceAbbott Point of CareAccutar BiotechnologyAdrienne G. Waks
Syneos Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Syneos Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Syneos Health page

4 registered trials is a research-attention snapshot, not an endorsement of Syneos Health or any single study.

  • 1 of Syneos Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hepatitis B is the condition Syneos Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hepatitis B trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Syneos Health pipeline card: 4 registered trials from official public datasets.Report a data error.